Dr. Frank Scorgie Rhame, MD

Dr. Rhame practices at Allina Health Uptown Clinic in Minneapolis, Minnesota.

Dr. Rhame's NPI, 1811959901, was assigned on April 4, 2006. Dr. Rhame graduated from Vagelos College of Physicians and Surgeons in 1968. Dr. Rhame's Minnesota license number on file is 24723.

Dr. Rhame's primary practice is Allina Health Uptown Clinic, at 1221 W Lake St Ste 201 Suite 201, Minneapolis, MN 55408. The practice phone is (612) 824-1772.

Dr. Rhame's primary practice is Allina Health Uptown Clinic in Minneapolis, Minnesota. Dr. Rhame is also affiliated with Abbott Northwestern Hospital. The medical group on file is Buffalo Hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rhame practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Rhame's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Rhame is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Rhame's licenses on file in 3 states: Minnesota, California and Georgia.

Dmand AI lists acute sinusitis, hiv/aids, pneumonia and UTI among the conditions Dr. Rhame treats.

CMS data shows 401 Medicare services from Dr. Rhame across 13 procedure codes in 2024, for 98 Medicare patients. Medicare paid $17,458 for them. Every service was in an office.

CMS counts 98 Medicare patients who saw Dr. Rhame in 2024. The largest group is under 65, with 39 patients. 52% of them have high blood pressure, and 48% have high cholesterol. 50% are also on Medicaid. Their average risk score is 1.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rhame's median patient age at 57, with 34% women.

In 2024, Dr. Rhame wrote 3,960 Medicare Part D claims for 182 patients. 62% of them were for generic drugs. CMS names the drug for 3,453 of them, across 90 drugs with 11 or more claims each, at $4,361,353 in total drug cost. In 2023, CMS named 3,387 claims across 82 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Rhame for performance year 2024, reported as part of a group. Dr. Rhame accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rhame as offering telehealth.

Dmand AI links 71 papers to Dr. Rhame, published from 2010 to 2021. 2011 was the busiest year, with 3. The most frequent topics are HIV Infections, Acquired Immunodeficiency Syndrome and Cross Infection. Dr. Rhame has published most often in Antimicrob Agents Chemother. Dr. Rhame's most frequent co-authors are Pragna Patel, MD, MPH, Irini Sereti, MD and Richard William Price, MD.

Dmand AI links Dr. Rhame to 4 clinical trials, 2 of them phase 2 studies. Conditions studied include Acquired Immunodeficiency Syndrome, Fibrosis and Severe Acute Respiratory Syndrome.

CMS Open Payments shows 359 general payments to Dr. Rhame from 10 drug and device companies from 2016 to 2024. Speaker and faculty fees make up the largest share, 60% of the total. ViiV Healthcare Company paid the most, $124,379. It also lists 8 research payments totaling $1,019 in 2018.

Dmand AI lists 3 awards for Dr. Rhame, most recently Regional Top Doctor in 2014.

Dr. Rhame graduated from Vagelos College of Physicians and Surgeons in 1968.

Dr. Rhame is in network with 15 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.